iOSAT™ is the first radiation protective tablet available to the general public. Experts agree that its prompt use would be the most effective way to protect millions of people who would be at risk in a nuclear accident or under a radiation threat from a nuclear weapon. They are FDA approved tablets that contain potassium iodide (KI) which provides protection from radioactive iodine (RAI), the contaminant that causes thyroid cancer.
iOSAT™ received its approval from the US Food and Drug Administration in 1982 and is the only full-strength table for radiation blocking. Only iOSAT™ has passed all FDA tests for purity, quality, safety and efficacy.
A single dose protects the thyroid gland for 24 hours. The shelf life of IOSAT 130 mg tablets is 7 years.